2014年第41卷第6期目录
|
|
封面故事:在癌症的靶向生物治疗过程中,多基因治疗将成为今后重要的发展趋势之一.而在多基因载体构建设计方法研究中,目前在翻译后水平寻找理想的连接子是多基因载体构建过程中一个重要的研究方向之一.章康健研究组利用不同的连接子多肽连接多个抗癌蛋白,对各连接子多肽剪切效果进行比较研究,探究了增强连接子剪切效果的影响因素,并对抗癌融合蛋白在翻译后水平剪切后的抗癌效应进行了检测.这为发现更好的翻译后水平剪切连接子研究提供了参考,同时为优化靶向癌症的多基因治疗策略设计提供了研究基础.本研究选用抗癌蛋白来研究连接子多肽而不是常用的GFP 等非人源标记基因,在癌症的多基因治疗领域中具有更强的应用设计和参考价值. (李红艳,周志明,潘 强,杨冬梅,顾锦法,沈佳妮,王世兵,章康健. 三种连接子多肽对抗癌融合蛋白翻译后剪切效果比较研究,本期第558~566页)
Cover Story:IL-24 and Smac are the important candidate genes for the targeting multi-genes therapy of cancer. In the construction of IL-24 and Smac dual gene expression vector, a stable and efficient linker is critical. We use three different linkers such as IETD, EEED and F2A to obtain three eukaryotic expression plasmids which are pcDNA3.1(+)-IL-24-IETD-Smac, pcDNA3.1(+)-IL-24-EEED-Smac, pcDNA3.1(+)-IL-24-F2A-Smac, and then combined with 5-fluorouracil (5-FU) treatment to study the cleavage efficiency of the three linker peptides. The results showed that among three IL-24-linker-Smac dual gene expression vectors, the F2A linker is superior to IETD and EEED linkers. In addition, its cleavage efficiency is positively correlated with activated caspases. Moreover, the fusion protein mediated by both IETD and EEED linker also can be cleaved,but their upstream IL-24 protein with 4 additional amino acid residues derived from IETD or EEED linker was detected with obvious degradation regulated by the ubiquitin-proteasome system. This study will provides a reference for the construction of dual-gene or muti-gene expression vector in cancer therapy.
|
综述与专论
研究快报
研究报告
技术与方法
|
|